Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population

Haematologica. 2023 Jan 1;108(1):240-244. doi: 10.3324/haematol.2022.281386.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myeloid* / drug therapy
  • Niacinamide / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles / therapeutic use

Substances

  • asciminib
  • Pyrazoles
  • Niacinamide
  • Protein Kinase Inhibitors